Adjusting for medication status in genome-wide association studies
Chong, A. H. W.; Kintu, C.; Cho, Y.; Fatumo, S.; Torres, J.; Davey Smith, G.; Gaunt, T. R.; Hemani, G.
Show abstract
When conducting genome-wide association studies, improper handling of medication status that is relevant to the trait of interest can induce biases by opening up different pathways that distort estimates of the true effect. Here, we propose the genetic empirical medication reduction adjustment (GEMRA) method which uses a heuristic search for an empirical adjustment to be applied to phenotypic values of participants reporting medication use. Through simulations we show that the direct genetic effect estimates in the GEMRA approach exhibited less bias and greater statistical power than either restricting the sample to unmedicated users, or including all samples without adjustment. We then applied the GEMRA approach to estimate statin medication adjustment for analysis of LDL cholesterol levels, using multi ancestry data from UK Biobank and the Uganda Genome Resource. We found that a relative rather than an absolute adjustment better modelled the effect of medication on LDL cholesterol, with an effect of 40% reduction appearing to be consistent across ancestral groups. These findings are consistent with the current clinical guidelines.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Genome-wide analysis of blood lipid metabolites in over 5,000 South Asians reveals biological insights at cardiometabolic disease loci 92%
- The relationships between women’s reproductive factors: a Mendelian randomization analysis 91%
- Helicobacter pylori seropositivity associates with hyperglycemia, but not obesity in Danish children and adolescents 91%
Similar papers in this journal
- An empirical investigation into the impact of winner's curse on estimates from Mendelian randomization 94%
- Educational attainment as a modifier of the effect of polygenic scores for cardiovascular risk factors: cross-sectional and prospective analysis of UK Biobank 94%
- Genetic Risk Scores for Cardiometabolic Traits in Sub-Saharan African Populations 93%
Similar papers in this journal
- Evaluating and implementing block jackknife resampling Mendelian randomization to mitigate bias induced by overlapping samples 93%
- Heritability and family-based GWAS analyses of the N-acyl ethanolamine and ceramide plasma lipidome 93%
- The impact of fatty acids biosynthesis on the risk of cardiovascular diseases in Europeans and East Asians: A Mendelian randomization study 93%
Similar papers in this journal
- Actionable absolute risk prediction of atherosclerotic cardiovascular disease: a behavior-management approach based on data from 464,547 UK Biobank participants 94%
- Baseline Cardiometabolic Profiles and SARS-CoV-2 Infection in the UK Biobank 93%
- A genome-wide analysis of DNA methylation identifies a novel association signal for Lp(a) concentrations in the LPA promoter 93%
Similar papers in this journal
- Evaluation of Bayesian Linear Regression Models for Gene Set Prioritization in Complex Diseases 94%
- Use of >100,000 NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium whole genome sequences improves imputation quality and detection of rare variant associations in admixed African and Hispanic/Latino populations 92%
- Proteome-wide Mendelian randomization identifies causal links between blood proteins and severe COVID-19 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.